Neither simple nor sequential arm movements are bradykinetic in parkinsonian patients with peak-dose dyskinesias

R. Agostino, S. Bagnato, L. Dinapoli, N. Modugno, A. Berardelli

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Objective: To find out whether parkinsonian patients with levodopa-induced peak-dose dyskinesias are bradykinetic. Methods: The performance of a sequential internally determined arm movement and a simple externally triggered arm movement was studied in a group of dyskinetic parkinsonian patients during their best clinical condition and when they were OFF treatment. Patients' performance was compared with that of an age-matched control group. Movements in the three-dimensional space were recorded by the ELITE motion analysis system. Kinematic variables analysed for the sequential motor task were total movement duration and total pause duration; for the simple motor task, movement duration and reaction time; and for both tasks, movement inaccuracy. Results: When patients were OFF therapy they performed sequential and simple movement tasks slower than healthy subjects whereas when they were dyskinetic they did not. During the sequential task, when the patients were dyskinetic total pause duration shortened and movement inaccuracy increased. Conclusions: Our kinematic finding indicates that parkinsonian patients' with peak-dose dyskinesias are not bradykinetic. Significance: Parkinsonian patients with peak-dose dyskinesias are not bradykinetic, probably because dopamine at peak doses functionally normalizes the mechanisms controlling movement speed.

Original languageEnglish
Pages (from-to)2077-2082
Number of pages6
JournalClinical Neurophysiology
Volume116
Issue number9
DOIs
Publication statusPublished - Sep 2005

Fingerprint

Dyskinesias
Biomechanical Phenomena
Levodopa
Dopamine
Healthy Volunteers
Research Design
Control Groups
Therapeutics

Keywords

  • Bradykinesia
  • Dyskinesias
  • Motor system
  • Parkinson's disease
  • Voluntary movement

ASJC Scopus subject areas

  • Clinical Neurology
  • Radiology Nuclear Medicine and imaging
  • Neurology
  • Sensory Systems
  • Physiology (medical)

Cite this

Neither simple nor sequential arm movements are bradykinetic in parkinsonian patients with peak-dose dyskinesias. / Agostino, R.; Bagnato, S.; Dinapoli, L.; Modugno, N.; Berardelli, A.

In: Clinical Neurophysiology, Vol. 116, No. 9, 09.2005, p. 2077-2082.

Research output: Contribution to journalArticle

@article{8dc599d4d1b54679a1886b02ef985b46,
title = "Neither simple nor sequential arm movements are bradykinetic in parkinsonian patients with peak-dose dyskinesias",
abstract = "Objective: To find out whether parkinsonian patients with levodopa-induced peak-dose dyskinesias are bradykinetic. Methods: The performance of a sequential internally determined arm movement and a simple externally triggered arm movement was studied in a group of dyskinetic parkinsonian patients during their best clinical condition and when they were OFF treatment. Patients' performance was compared with that of an age-matched control group. Movements in the three-dimensional space were recorded by the ELITE motion analysis system. Kinematic variables analysed for the sequential motor task were total movement duration and total pause duration; for the simple motor task, movement duration and reaction time; and for both tasks, movement inaccuracy. Results: When patients were OFF therapy they performed sequential and simple movement tasks slower than healthy subjects whereas when they were dyskinetic they did not. During the sequential task, when the patients were dyskinetic total pause duration shortened and movement inaccuracy increased. Conclusions: Our kinematic finding indicates that parkinsonian patients' with peak-dose dyskinesias are not bradykinetic. Significance: Parkinsonian patients with peak-dose dyskinesias are not bradykinetic, probably because dopamine at peak doses functionally normalizes the mechanisms controlling movement speed.",
keywords = "Bradykinesia, Dyskinesias, Motor system, Parkinson's disease, Voluntary movement",
author = "R. Agostino and S. Bagnato and L. Dinapoli and N. Modugno and A. Berardelli",
year = "2005",
month = "9",
doi = "10.1016/j.clinph.2005.04.027",
language = "English",
volume = "116",
pages = "2077--2082",
journal = "Clinical Neurophysiology",
issn = "1388-2457",
publisher = "Elsevier Ireland Ltd",
number = "9",

}

TY - JOUR

T1 - Neither simple nor sequential arm movements are bradykinetic in parkinsonian patients with peak-dose dyskinesias

AU - Agostino, R.

AU - Bagnato, S.

AU - Dinapoli, L.

AU - Modugno, N.

AU - Berardelli, A.

PY - 2005/9

Y1 - 2005/9

N2 - Objective: To find out whether parkinsonian patients with levodopa-induced peak-dose dyskinesias are bradykinetic. Methods: The performance of a sequential internally determined arm movement and a simple externally triggered arm movement was studied in a group of dyskinetic parkinsonian patients during their best clinical condition and when they were OFF treatment. Patients' performance was compared with that of an age-matched control group. Movements in the three-dimensional space were recorded by the ELITE motion analysis system. Kinematic variables analysed for the sequential motor task were total movement duration and total pause duration; for the simple motor task, movement duration and reaction time; and for both tasks, movement inaccuracy. Results: When patients were OFF therapy they performed sequential and simple movement tasks slower than healthy subjects whereas when they were dyskinetic they did not. During the sequential task, when the patients were dyskinetic total pause duration shortened and movement inaccuracy increased. Conclusions: Our kinematic finding indicates that parkinsonian patients' with peak-dose dyskinesias are not bradykinetic. Significance: Parkinsonian patients with peak-dose dyskinesias are not bradykinetic, probably because dopamine at peak doses functionally normalizes the mechanisms controlling movement speed.

AB - Objective: To find out whether parkinsonian patients with levodopa-induced peak-dose dyskinesias are bradykinetic. Methods: The performance of a sequential internally determined arm movement and a simple externally triggered arm movement was studied in a group of dyskinetic parkinsonian patients during their best clinical condition and when they were OFF treatment. Patients' performance was compared with that of an age-matched control group. Movements in the three-dimensional space were recorded by the ELITE motion analysis system. Kinematic variables analysed for the sequential motor task were total movement duration and total pause duration; for the simple motor task, movement duration and reaction time; and for both tasks, movement inaccuracy. Results: When patients were OFF therapy they performed sequential and simple movement tasks slower than healthy subjects whereas when they were dyskinetic they did not. During the sequential task, when the patients were dyskinetic total pause duration shortened and movement inaccuracy increased. Conclusions: Our kinematic finding indicates that parkinsonian patients' with peak-dose dyskinesias are not bradykinetic. Significance: Parkinsonian patients with peak-dose dyskinesias are not bradykinetic, probably because dopamine at peak doses functionally normalizes the mechanisms controlling movement speed.

KW - Bradykinesia

KW - Dyskinesias

KW - Motor system

KW - Parkinson's disease

KW - Voluntary movement

UR - http://www.scopus.com/inward/record.url?scp=24344478783&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24344478783&partnerID=8YFLogxK

U2 - 10.1016/j.clinph.2005.04.027

DO - 10.1016/j.clinph.2005.04.027

M3 - Article

VL - 116

SP - 2077

EP - 2082

JO - Clinical Neurophysiology

JF - Clinical Neurophysiology

SN - 1388-2457

IS - 9

ER -